Detalhe da pesquisa
1.
Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial.
Breast Cancer Res
; 26(1): 9, 2024 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212845
2.
An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation.
Cancer
; 130(S8): 1513-1523, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38427584
3.
CT Radiomics for Predicting Pathological Complete Response of Axillary Lymph Nodes in Breast Cancer After Neoadjuvant Chemotherapy: A Prospective Study.
Oncologist
; 28(4): e183-e190, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802345
4.
Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study.
Breast Cancer Res Treat
; 195(3): 301-310, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35917052
5.
Effect of Local Versus General Anesthesia in Breast-Conserving Surgery on Cancer Recurrence and Cost.
Cancer Control
; 29: 10732748221083078, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35459407
6.
Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: long-term results using propensity score adjustment method.
Breast Cancer Res Treat
; 183(3): 717-728, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32715444
7.
Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China.
Breast Cancer Res Treat
; 175(3): 749-754, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30895535
8.
Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer.
Support Care Cancer
; 27(8): 3019-3025, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30607682
9.
99mTc-rituximab as a tracer for sentinel lymph node biopsy in breast cancer patients: a single-center analysis.
Breast Cancer Res Treat
; 168(2): 365-370, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29209873
10.
A new model to predict risk of nonsentinel lymph node status in Chinese sentinel lymph node-positive patients after neoadjuvant chemotherapy.
Breast J
; 24(6): 883-888, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29781094
11.
A single-center, randomized, parallel controlled study comparing the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer.
Breast Cancer Res Treat
; 157(3): 527-34, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27250001
12.
Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations.
Breast Cancer Res Treat
; 156(3): 441-445, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27033093
13.
Early prediction of pathological outcomes to neoadjuvant chemotherapy in breast cancer patients using automated breast ultrasound.
Chin J Cancer Res
; 28(5): 478-485, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27877006
14.
Efficacy of physical examination, ultrasound, and ultrasound combined with fine-needle aspiration for axilla staging of primary breast cancer.
Breast Cancer Res Treat
; 149(3): 761-5, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25667099
15.
[Impact of response of primary tumor and positive axillary lymph node to neoadjuvant chemotherapy on breast cancer survival].
Zhonghua Yi Xue Za Zhi
; 95(4): 256-9, 2015 Jan 27.
Artigo
em Zh
| MEDLINE | ID: mdl-25877239
16.
[Risk factors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node ≤ 2].
Zhonghua Yi Xue Za Zhi
; 94(30): 2355-8, 2014 Aug 13.
Artigo
em Zh
| MEDLINE | ID: mdl-25399977
17.
[Risk factors for non-sentinel lymph node metastasis in patients after neoadjuvant chemotherapy].
Zhonghua Yi Xue Za Zhi
; 94(34): 2661-4, 2014 Sep 16.
Artigo
em Zh
| MEDLINE | ID: mdl-25511592
18.
[Safety of omitting axillary lymph node dissection in primary breast cancer patients with negative sentinel lymph nodes].
Zhonghua Yi Xue Za Zhi
; 93(40): 3220-2, 2013 Oct 29.
Artigo
em Zh
| MEDLINE | ID: mdl-24405545
19.
[Reliability of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 expression in breast cancer evaluated by immunohistochemistry].
Zhonghua Yi Xue Za Zhi
; 93(32): 2571-3, 2013 Aug 27.
Artigo
em Zh
| MEDLINE | ID: mdl-24351599
20.
[Survival analysis for different molecular subtypes of breast cancers after treatment].
Zhonghua Yi Xue Za Zhi
; 93(46): 3663-6, 2013 Dec.
Artigo
em Zh
| MEDLINE | ID: mdl-24534345